NFKB1 and cancer: In contrast, low-risk cells were associated with immune-related pathways, including the T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, NF-κB signaling pathway, NK cell-mediated cytotoxicity, and others (Figure 5D).